Vitamin E and neurodegenerative disorders associated with oxidative stress

Nutritional Neuroscience

Volumn 5, Issue 4, 2002, Pages 229-239

  Butterfield, D Allan ^a   Castegna, Alessandra ^a   Drake, Jennifer ^a   Scapagnini, Giovanni ^b   Calabrese, Vittorio ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b Blanchette Rockefeller Neurosciences Institute   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Lipid peroxidation; Neurodegenerative disorders; Oxidative stress; Protein oxidation; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOMORPHINE; ASCORBIC ACID; CATECHOLAMINE; COPPER ZINC SUPEROXIDE DISMUTASE; DOPA; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; LEVODOPA; LIPID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDOPAMINE; OXYGEN; PEROXYNITRITE; PLACEBO; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HUNTINGTON CHOREA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVIEW; TARDIVE DYSKINESIA; BIOAVAILABILITY; CHEMISTRY; DYSKINESIA; INTESTINE ABSORPTION; PHYSIOLOGY;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL AVAILABILITY; DYSKINESIAS; HUMAN; HUNTINGTON DISEASE; INTESTINAL ABSORPTION; LIPID PEROXIDATION; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; PARKINSON DISEASE; SUPPORT, U.S. GOV'T, P.H.S.; VITAMIN E; HUMANS;

ANIMALIA;

EID: 0035988588     PISSN: 1028415X     EISSN: None     Source Type: Journal    
DOI: 10.1080/10284150290028954     Document Type: Review

References (108)

1. "Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis"
2. "Vitamin E treatment for tardive dyskinesia"
3. "Recent advances in amyotrophic lateral sclerosis"
4. "Vitamin E: Non-antioxidant roles"
5. "Vitamin E and other antioxidants in neuroprotection"
6. "Vitamin E in extrapyramidal disorders"
7. "Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains"
8. "Blood oxidative stress in amyotrophic lateral sclerosis"
9. "Vitamin E in the treatment of tardive dyskinesia"
10. "Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients"
11. "Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex"
12. Oxidative stress in Huntington's disease
13. "Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?"
14. "Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis"
15. "Protein oxidation processes in aging brain"
16. "Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated"
17. "Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: Insights into Alzheimer's disease"
18. "Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide"
19. "The α-tocopherol and phospholipid fatty acid content of rat liver subcellular membranes in vitamin E and selenium deficiency"
20. "Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA): Behavioral and biochemical evidence"
21. "Changes in cerebrospinal fluid levels of malonaldehyde and glutathione reductase activity in Multiple sclerosis"
22. "Increased cerebrospinal fluid and plasma levels of ultraweak chemiluminescence are associated with changes in the thiol pool and lipid-soluble fluorescence in multiple sclerosis: The pathogenic role of oxidative stress"
23. "The generation of hydrogen peroxide, superoxide radical, and hydroxyradical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents"
24. "Bioavailability of vitamin E"
25. "Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis"
26. "A double-blind placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis"
27. "Therapeutic trial in amyotrophic lateral sclerosis"
28. "Medical utility of apoe allele determination in assessing the need for antioxidant therapy"
29. "α-tocopherol binding proteins: Purification and characterization"
30. "Oxidative stress and antioxidant therapy in Parkinson's disease"
31. "Tardive dyskinesia: Possible involvement of free radicals and treatment with vitamin E"
32. "Fetal resorption"
33. "A pilot trial of high dose alfa tocopherol and ascorbate in early Parkinson's disease"
34. Dietary reference intakes for vitamin C, vitamin E selenium and carotenoids
35. "Nutritional factors in the aetiology of multiple sclerosis: A case-control study in Monteal, Canada"
36. "Case-control study of early life dietary factors in Parkinson's disease"
37. "Vitamin E and Alzheimer disease: The basis for additional clinical trials"
38. "Transgenic animal models of familial amyotrophic lateral sclerosis"
39. "Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation"
40. "Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis"
41. "Environmental risk factors in MS: A case-control study in Moscow"
42. "Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS"
43. "Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment"
44. "Role of free radicals and catalytic metal ions in human disease: An overview"
45. "Pentamethyl-hydroxychromane, vitamin E derivative, inhibits induction of nitric oxide synthase by bacterial lipopolysaccharide"
46. "Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis"
47. "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group"
48. "Vitamin A and E levels are normal in amyotrophic lateral sclerosis"
49. "γ-tocopherol, the major form of vitamin E in the US diet, deserves more attention"
50. "Chemical neurotoxins as denervation tools in neurobiology"
51. "Oxidant treatment causes a dose-dependent phenotype of apoptosis in cultured motoneurons"
52. "Nonenzymatic antioxidants of blood in multiple sclerosis"
53. "Advances in Alzheimer's disease"
54. "Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease"
55. "Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition"
56. "3-nitropropionic acid induced in vivo protein oxidation in striatal and cortical synaptosomes: Insights into Huntington's disease"
57. "Measurement of low-molecular-weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis"
58. "The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Abeta1-42"
59. "Vulnerability of synaptosomes from apoE knock-out mice to structural and oxidative modifications induced by A beta(1-40): Implications for Alzheimer's disease"
60. "Apolipoprotein E modulates Alzheimer's A beta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner"
61. "Oxidative stress effect on the activation of hepatic stellate cells"
62. "T cell-T cell activation in multiple sclerosis"
63. "Dietary lipids and antioxidants in parkinson's disease: A population-based, case-control study"
64. "A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia"
65. "Whither vitamin E and tardive dyskinesia?"
66. "Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms"
67. "Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia"
68. "Association of vitamin E and C supplement use with cognitive function and dementia in elderly men"
69. "Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: Implications for multiple sclerosis"
70. "Vitamin E and vitamin C supplement use and risk of incidence in Alzheimer disease"
71. "Plasma levels of vitamin E in Parkinson's disease"
72. "Multiple sclerosis: An altered immune response or an altered stress response?"
73. "The small heat shock protein alpha B-crystallin as key autoantigen in multiple sclerosis"
74. "Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients"
75. "Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis"
76. "Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients"
77. "The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells"
78. "Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging system in rat brain"
79. "Trial of D-alpha-tocopherol in Huntington's disease"
80. "Lou Gehrig and amyotrophic lateral sclerosis. Is vitamin E to be revisited?"
81. "Dietary antioxidants and Parkinson's disease"
82. "Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: Behavioral and histochemical evidence"
83. "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis"
84. "Apolipoprotein E alleles as risk factors in Alzheimer's disease"
85. "A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study"
86. "The spectrum of neurologic disorder from vitamin E deficiency"
87. "Relationship between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections"
88. "The unilateral 6-hydroxydopamine lesion model in behavioral brain research: Analysis of functional deficits, recovery and treatments"
89. "CSF and plasma amino acid levels in motor neuron disease: Elevation of CSF glutamate in a subset of patients"
90. "DATATOP: A decade of neuroprotective inquiry"
91. "Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination"
92. "Multiple sclerosis: Fat-oil relationship"
93. "Glutathione peroxidase activity in various types of blood cells in multiple sclerosis"
94. "Vitamin E for Alzheimer's disease"
95. "Antioxidant drugs block in vitro the neurotoxicity of CSF from patients with amyotrophic lateral sclerosis"
96. "Trials to slow progression and prevent disease onset"
97. "Unsaturated Fatty Acids in Multiple Sclerosis"
98. "alpha-Tocopherol quinone level is remarkably low in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis"
99. "Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis"
100. "Evidence for increased lipid peroxidation in multiple sclerosis"
101. "The differential diagnosis of multiple sclerosis: Classification and clinical features of relapsing and progressive neurological syndromes"
102. "Postsynaptic supersensitivity after 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine system"
103. "Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity"
104. "High doses of vitamin E in the treatment of disorders of the central nervous system in the aged"
105. "Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice"
106. "Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants"
107. "Vitamin E prevents Alzheimer's amyloid-peptide (1-42)-induced protein oxidation and reactive oxygen species formation"
108. "Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women"